Brain Startup Synchron Says AI Will Be Instrumental for Devices.

OPENAI Inc.; ARTIFICIAL intelligence; AMYOTROPHIC lateral sclerosis; CAREGIVERS

Brain-computer startup Synchron Inc. is using OpenAI's latest artificial intelligence models to help paralyzed patients communicate through its implant. The device, called the Stentrode, is implanted into the brain via a vein in the neck and can communicate a patient's desired actions to a tablet computer. The integration of the Stentrode with OpenAI's GPT-4o model allows for easier drafting of written responses and could potentially lead to enhanced brainpower for both paralyzed and healthy individuals. Synchron emphasizes that it does not share any brain data with OpenAI, but rather uses inputs from the user's environment to suggest responses. The technology has the potential to greatly improve the independence and quality of life for patients with conditions such as amyotrophic lateral sclerosis (ALS). Synchron is still in the early stages of testing the device and plans to apply for FDA approval in the future. [Extracted from the article]

Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)